Angiotensin-converting enzyme and apolipoproteins genes polymorphism in coronary artery disease

Background: Association between angiotensin-converting enzyme (ACE) as well as apolipoprotein (apo) AI, B, and E polymorphisms and dyslipidemia and co ronary artery disease (CAD) is controversial. Hypothesis: This study assessed the distribution of ACE insertion/deletion, apo AI A/G mutation, apo B signal peptide insertion/deletion, apo B XbaI r estriction fragment length, and apo E polymorphisms in 388 nondiabetic pati ents. Methods: The study population included 112 patients with stable CAD, 139 pa tients with acute myocardial infarction (AMI), and 137 age-matched control subjects. Results: Univariate analysis showed higher prevalence of XbaI X+/X+ genotyp e in patients with CAD (p = 0.02). Angiotensin-converting enzyme and apo po lymorphisms were not associated with Lipid levels or severity of CAD. When all genotypes known to be related to CAD, such as ACE DD, apo Al GG, apo B del/del, and XbaI X+X+, and Ecl allele of apo E, were pooled, again no sign ificant differences among groups were seen. Multivariate regression analysi s disclosed traditional risk factors and elevated levels of apo B for men a nd reduced levels of apo AI for women as independent variables for CAD. Conclusions: In addition to traditional coronary risk factors, apo B and AI could be considered predictors of CAD. No association between either form of CAD and polymorphisms was noted.